Insulet [PODD] vs Stryker [SYK] Detailed Stock Comparison

Insulet Corporation

NASDAQ
Loading...

Stryker Corporation

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Insulet Corporation wins in 6 metrics, Stryker Corporation wins in 14 metrics, with 0 ties. Stryker Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Insulet Corporation Stryker Corporation Better
P/E Ratio (TTM) 55.27 39.21 Stryker Corporation
Price-to-Book Ratio 8.93 5.62 Stryker Corporation
Debt-to-Equity Ratio 66.18 72.97 Insulet Corporation
PEG Ratio 23.80 0.72 Stryker Corporation
EV/EBITDA 24.51 19.90 Stryker Corporation
Profit Margin (TTM) 9.12% 12.92% Stryker Corporation
Operating Margin (TTM) 18.67% 27.24% Stryker Corporation
EBITDA Margin (TTM) 18.67% 27.24% Stryker Corporation
Return on Equity 18.12% 15.08% Insulet Corporation
Return on Assets (TTM) 9.43% 7.92% Insulet Corporation
Free Cash Flow (TTM) $349.90M $4.28B Stryker Corporation
Dividend Yield N/A 0.97% N/A
1-Year Return -50.86% -17.25% Stryker Corporation
Price-to-Sales Ratio (TTM) 5.00 5.02 Insulet Corporation
Enterprise Value $13.83B $138.30B Stryker Corporation
EV/Revenue Ratio 5.11 5.51 Insulet Corporation
Gross Profit Margin (TTM) 72.54% 64.54% Insulet Corporation
Revenue per Share (TTM) $39 $66 Stryker Corporation
Earnings per Share (Diluted) $3.48 $8.40 Stryker Corporation
Beta (Stock Volatility) 1.47 0.93 Stryker Corporation
Short % of Float 4.97% 1.20% Stryker Corporation

Insulet Corporation vs Stryker Corporation Stock Performance Analysis

Loading Price Chart...

PODD
SYK

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Insulet Corporation-1.04%-2.22%0.46%-34.06%-49.18%-47.64%
Stryker Corporation-1.36%2.13%0.38%-11.91%-13.33%-11.56%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Insulet Corporation-50.86%-47.38%-46.64%417.99%674.84%886.17%
Stryker Corporation-17.25%6.06%22.47%172.95%440.98%592.85%

Performance & Financial Health Analysis: Insulet Corporation vs Stryker Corporation

MetricPODDSYK
Market Information
Market Cap i$13.53B$126.25B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i743,3711,881,406
90 Day Avg. Volume i897,9602,161,139
Last Close$148.14$307.94
52 Week Range$140.63 - $354.88$281.00 - $404.87
% from 52W High-58.26%-23.94%
All-Time High$354.88 (Nov 20, 2025)$406.19 (Jan 27, 2025)
% from All-Time High-58.26%-24.19%
Growth Metrics
Quarterly Revenue Growth0.31%0.11%
Quarterly Earnings Growth0.01%0.56%
Financial Health
Profit Margin (TTM) i0.09%0.13%
Operating Margin (TTM) i0.19%0.27%
Return on Equity (TTM) i0.18%0.15%
Debt to Equity (MRQ) i66.1872.97
Cash & Liquidity
Book Value per Share (MRQ)$21.53$58.61
Cash per Share (MRQ)$10.17$10.71
Operating Cash Flow (TTM) i$569.30M$5.04B
Levered Free Cash Flow (TTM) i$154.90M$4.17B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A$3.40

Valuation & Enterprise Metrics Analysis: Insulet Corporation vs Stryker Corporation

MetricPODD (Apr 24, 2026)SYK (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i55.2739.21
Forward P/E i23.8019.67
PEG Ratio i23.800.72
Price to Sales (TTM) i5.005.02
Price to Book (MRQ) i8.935.62
Market Capitalization
Market Capitalization i$13.53B$126.25B
Enterprise Value i$13.83B$138.30B
Enterprise Value Metrics
Enterprise to Revenue i5.115.51
Enterprise to EBITDA i24.5119.90
Risk & Other Metrics
Beta i1.470.93
Book Value per Share (MRQ) i$21.53$58.61

Financial Statements Comparison: Insulet Corporation vs Stryker Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricPODD (2025)SYK (2025)
Revenue/Sales i2.71B25.12B
Cost of Goods Sold i768.20M9.05B
COGS % of Revenue i28.4%36.0%
Gross Profit i1.94B16.07B
Gross Margin i71.6%64.0%
Research & Development i301.10M1.62B
Operating Income (EBIT) i473.80M5.06B
Operating Margin i17.5%20.1%
EBITDA i600.70M6.48B
EBITDA Margin i22.2%25.8%
Pre-Tax Income i339.50M4.51B
Pre-Tax Income % of Revenue i12.5%18.0%
Income Tax i92.40M1.27B
Income Tax % of Revenue i3.4%5.0%
Net Income (Profit) i247.10M3.25B
Profit Margin i9.1%12.9%

Balance Sheet & Liquidity Metrics

MetricPODD (2025)SYK (2025)
Cash & Equivalents i716.10M4.01B
Total Current Assets i1.91B14.76B
Total Current Assets % of Revenue i70.7%58.7%
Total Current Liabilities i680.10M7.79B
Total Current Liabilities % of Revenue i25.1%31.0%
Long-Term Debt i930.80M14.86B
Long-Term Debt % of Revenue i34.4%59.2%
Total Shareholders Equity i1.52B22.42B
Retained Earnings i287.40M20.47B
Retained Earnings % of Revenue i10.6%81.5%
Property, Plant & Equipment i01.79B

Cash Flow Statement Comparison

MetricPODD (2025)SYK (2025)
Operating Cash Flow i374.00M4.70B
Operating Cash Flow % of Revenue i13.8%18.7%
Capital Expenditures iN/A-761.00M
Free Cash Flow i349.90M4.28B
FCF Margin i12.9%17.1%
Debt Repayment i-1.21B-1.40B
Common Stock Repurchase i-59.60MN/A

Short Interest & Institutional Ownership Analysis

MetricPODDSYK
Shares Short i3.05M4.42M
Short Ratio i3.131.95
Short % of Float i4.97%1.20%
Shares Outstanding i70.39M382.50M
Float Shares i70.10M346.55M
% Held by Insiders i0.31%5.37%
% Held by Institutions i105.62%82.09%
% Held by Public i-5.93%12.54%

Dividend Analysis & Yield Comparison: Insulet Corporation vs Stryker Corporation

MetricPODDSYK
Last 12-Month Dividend iN/A$3.40
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A$3.23
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$9.69
Ex-Dividend DateN/ADec 31, 2025